Updates in chronic subdural hematoma: epidemiology, etiology, pathogenesis, treatment, and outcome

J Feghali, W Yang, J Huang - World neurosurgery, 2020 - Elsevier
Chronic subdural hematoma (CSDH) is a complex disease with an overall incidence of 1.7–
20.6 per 100,000 persons per year and is more commonly encountered in the elderly …

Radiological prognostic factors of chronic subdural hematoma recurrence: a systematic review and meta-analysis

IP Miah, Y Tank, FR Rosendaal, WC Peul, R Dammers… - Neuroradiology, 2021 - Springer
Purpose Chronic subdural hematoma (CSDH) is associated with high recurrence rates.
Radiographic prognostic factors may identify patients who are prone for recurrence and who …

Middle meningeal artery embolization for chronic subdural hematoma: predictors of clinical and radiographic failure from 636 embolizations

MM Salem, O Kuybu, A Nguyen Hoang, AA Baig… - Radiology, 2023 - pubs.rsna.org
Background Knowledge regarding predictors of clinical and radiographic failures of middle
meningeal artery (MMA) embolization (MMAE) treatment for chronic subdural hematoma …

[HTML][HTML] Chronic Subdural Hematoma (cSDH): A review of the current state of the art

A Nouri, R Gondar, K Schaller, T Meling - Brain and Spine, 2021 - Elsevier
Abstract Introduction Incidence of Chronic Subdural Hematoma (cSDH) is rising worldwide,
partly due to an aging population, but also due to increased use of antithrombotic …

Middle meningeal artery embolization reduces the post-operative recurrence rate of at-risk chronic subdural hematoma

E Shotar, L Meyblum, K Premat, S Lenck… - Journal of …, 2020 - jnis.bmj.com
Background Embolization of the middle meningeal artery (MMA) has emerged as a potential
treatment of chronic subdural hematomas (CSDHs). Objective To evaluate the impact on …

Factors correlated with the postoperative recurrence of chronic subdural hematoma: an umbrella study of systematic reviews and meta-analyses

F Zhu, H Wang, W Li, S Han, J Yuan, C Zhang… - …, 2022 - thelancet.com
Background Chronic subdural hematoma (CSDH) is a common neurological disease, and
the surgical evacuation of subdural collection remains the primary treatment approach for …

Predictors of acute intracranial hemorrhage and recurrence of chronic subdural hematoma following burr hole drainage

FM Chen, K Wang, KL Xu, L Wang, TX Zhan, F Cheng… - BMC neurology, 2020 - Springer
Background To investigate predictors of postoperative acute intracranial hemorrhage (AIH)
and recurrence of chronic subdural hematoma (CSDH) after burr hole drainage. Methods A …

[HTML][HTML] Treatment of chronic subdural hematoma with atorvastatin combined with low-dose dexamethasone: phase II randomized proof-of-concept clinical trial

D Wang, C Gao, X Xu, T Chen, Y Tian, H Wei… - Journal of …, 2020 - thejns.org
OBJECTIVE The authors sought to test the hypothesis that adding dexamethasone (DXM) to
atorvastatin (ATO) potentiates the effects of ATO on chronic subdural hematoma (CSDH) …

Clinical and radiological factors predicting recurrence of chronic subdural hematoma: a retrospective cohort study

J Shen, L Yuan, R Ge, Q Wang, W Zhou, XC Jiang… - Injury, 2019 - Elsevier
Background Chronic subdural hematoma (CSDH) is commonly encountered in the elderly
patients and the recurrence rate is still high, therefore, identifying risk factors for CSDH …

Middle meningeal artery embolization for treatment of chronic subdural hematomas: does selection of embolized branches affect outcomes?

MH Khorasanizadeh, M Shutran, A Garcia… - Journal of …, 2022 - thejns.org
OBJECTIVE Middle meningeal artery (MMA) embolization (MMAE) is a new therapeutic
modality for chronic subdural hematoma (cSDH). There is limited evidence comparing …